Loading data...
Glista Co., Ltd.
Representative Director
Toshi Saito
N/A
Recent News & PR
Summary
Message to Participants
Detailed Information
The only business-focused genetic analysis in Japan. Healthcare providers can develop their own 'custom genetic kits' to personalize their services quickly, accurately, and at a low cost.
Unfair Advantage & Strengths
N/A
Competitors
N/A
Company Profile
事業カテゴリ
SaaS / B2Bソフトウェア, Healthcare / Biotech
本社所在地
Chuo-ku, Tokyo, Japan
設立日
2014年7月1日
資本金
N/A
Employee Count
6
Industry Outlook & Trends for Glista Co., Ltd.
In the B2B SaaS and software market where Glista Co., Ltd. operates, rapid growth continues to be driven by corporate digital transformation (DX). Beyond general-purpose tools, specialized Vertical SaaS that automates industry-specific workflows is rising. Furthermore, integration with AI is transforming SaaS into intelligent platforms. To address global labor shortages, innovative solutions like those provided by Glista Co., Ltd. continue to grow as an indispensable business infrastructure.
🔒
VPO Investor Pro Features
You are viewing a basic startup profile. Create a free account to access the dashboard. You can also upgrade to the "Investor Pro" plan to unlock full access to the following premium databases and features:
🎬
Elevator & Full Pitch Video
Watch full presentations with English/Japanese subtitles.
📊
AI Quick Report & Valuation
Get AI-driven assessment scores on market, product, and traction.
📅
Priority Challenges & Hiring
Access core corporate bottlenecks and current hiring plans.
📝
Full Transcripts
Read full pitch dialogue in both English and Japanese.
📈
Financials & Exit Strategy
Unlock IPO/M&A timelines and debt/equity plans.
👥
Advisors & Key Members
View internal team details and advisory board configurations.